Reviewing vendors that “cater to the more complex needs of IDNs and CINs,” KLAS 2017 Population Health Management Report Part 2 called Arcadia one of “the most consistent in delivering satisfaction across multiple PHM verticals, specifically the data-focused verticals.”[2] This report found that on average, Arcadia’s technology manages more lives per customer than any other rated population health vendor.[3]

Figure 1: Average Number of Lives Managed, fully rated vendors and vendors below Konfidence. Data from Figure 3 on Page 17

The report demonstrates Arcadia’s ability to maintain high levels of customer satisfaction while leading the market in connectivity to EHR and claims systems.[4] “The vendors who most consistently have customers deploying data aggregation functionality are often non-EMR vendors, who are more responsive, timely, and flexible in helping customers aggregate numerous and complicated data sources,” said KLAS.[5]

Figure 2: Vendor Performance vs. Adoption – Data Aggregation, fully rated vendors and vendors below Konfidence. Data from Figure 6 on Page 20.

KLAS cited Arcadia’s strength in integrating many types of data with a high level of quality, quoting one customer who said, “Arcadia Analytics becomes a very powerful tool in a number of areas. All of the data, including the EMR data, charge data, and appointments, is collected by Arcadia Analytics. The system combines our clinical data and claims fees from our major payer and matches up claims. In some reports, the system shows us significant differences.”[6]

“There is a dangerous misperception that a high-quality, usable data asset capable of powering a value-based strategy is a commodity.” said Arcadia chief executive officer Sean Carroll. “Time and again, we see organizations that prioritize their data strategy are much more likely to achieve their desired clinical and financial outcomes under risk. We’re very gratified to hear our customers validate through KLAS feedback our belief that great population health management software can only be achieved with a superior data asset. We look forward to ongoing feedback from our customers as it truly helps guide our roadmap and investment decisions.”

Strong backing from investors, including Merck Global Health Innovation Fund (“Merck GHI”), GE Ventures, Peloton Equity, Zaffre Investments, and Morgan Stanley Alternative Investment Partners, ensures Arcadia is well-positioned to continue a rapid growth trajectory in 2018. Arcadia plans significant investment in platform development this year to continue to drive clinical and financial outcomes for providers and health plans transitioning to value-based care.

“We’ve benefited from an extraordinary level of collaboration with our customers as we’ve built our new platform capabilities,” said Arcadia chief analytics officer Michael Gleeson. “For example, our Care Management module, is built both on the best longitudinal patient record in the industry, and thoughtful input from leading healthcare organizations like Beth Israel Deaconess Care Organization.”

Arcadia customers will preview Arcadia’s newest product capabilities and latest proprietary technology at Arcadia Aggregate 2018 in April. Aggregate is Arcadia’s annual industry conference bringing together Arcadia customers, industry experts and analysts, and healthcare thought leaders.

  1. Page 5 of 2017 Population Health Management Report Part 2.
  2. Page 5 of 2017 Population Health Management Report Part 2.
  3. Page 16 of 2017 Population Health Management Report Part 2.
  4. Page 20 of 2017 Population Health Management Report Part 2.
  5. Page 20 of 2017 Population Health Management Report Part 2.
  6. Page 20 of 2017 Population Health Management Report Part 2.